Credit Suisse’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $421K | Buy |
39,683
+1,647
| +4% | +$17.5K | ﹤0.01% | 2704 |
|
|
2023
Q4 | $347K | Sell |
38,036
-2
| -0% | -$18 | ﹤0.01% | 2878 |
|
|
2023
Q3 | $394K | Sell |
38,038
-1,426
| -4% | -$14.8K | ﹤0.01% | 2806 |
|
|
2023
Q2 | $565K | Buy |
39,464
+22,803
| +137% | +$327K | ﹤0.01% | 2697 |
|
|
2023
Q1 | $119K | Buy |
16,661
+1,216
| +8% | +$8.68K | ﹤0.01% | 3172 |
|
|
2022
Q4 | $173K | Buy |
15,445
+4,633
| +43% | +$52K | ﹤0.01% | 3207 |
|
|
2022
Q3 | $120K | Buy |
10,812
+491
| +5% | +$5.45K | ﹤0.01% | 3380 |
|
|
2022
Q2 | $88K | Buy |
+10,321
| New | +$88K | ﹤0.01% | 3545 |
|
|
2021
Q4 | – | Sell |
-8,429
| Closed | -$271K | – | 3697 |
|
|
2021
Q3 | $271K | Buy |
8,429
+1,830
| +28% | +$58.8K | ﹤0.01% | 3289 |
|
|
2021
Q2 | $224K | Buy |
6,599
+1,233
| +23% | +$41.9K | ﹤0.01% | 3399 |
|
|
2021
Q1 | $202K | Sell |
5,366
-2,560
| -32% | -$96.4K | ﹤0.01% | 3268 |
|
|
2020
Q4 | $264K | Buy |
+7,926
| New | +$264K | ﹤0.01% | 3175 |
|